Top Markets
Coin of the day
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Classifica tra le azioni #32245
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Prezzo delle azioni
$4.65
Ultima sincronizzazione: 2024-07-24
Capitalizzazione di mercato
$10.63M
Variazione (1 giorno)
6.66%
Variazione (1 anno)
0.00%
Paese
AU
Scambia Medlab Clinical Limited (MDC)

Categoria

Cronologia dei frazionamenti azionari per Medlab Clinical Limited (MDC)
L’azione Medlab Clinical Limited (simbolo: MDC) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 18, 2026.
Una quota di MDC acquistata prima di Aug 18, 2026 equivale oggi a 0 quote di MDC.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR